ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 129 filers reported holding ANI PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $476,092 | +21.2% | 8,200 | +12.3% | 0.01% | +22.2% |
Q2 2023 | $392,959 | +73.6% | 7,300 | +28.1% | 0.01% | +50.0% |
Q1 2023 | $226,404 | +97069.1% | 5,700 | -1.7% | 0.01% | 0.0% |
Q4 2022 | $233 | -99.9% | 5,800 | -6.5% | 0.01% | +20.0% |
Q1 2022 | $203,000 | -15.4% | 6,200 | +19.2% | 0.01% | 0.0% |
Q4 2021 | $240,000 | -3.2% | 5,200 | +52.9% | 0.01% | -61.5% |
Q3 2019 | $248,000 | -1.6% | 3,400 | +9.7% | 0.01% | 0.0% |
Q2 2019 | $252,000 | +15.1% | 3,100 | 0.0% | 0.01% | +18.2% |
Q1 2019 | $219,000 | +7.4% | 3,100 | -13.9% | 0.01% | +22.2% |
Q3 2018 | $204,000 | -25.5% | 3,600 | -12.2% | 0.01% | -25.0% |
Q2 2018 | $274,000 | +17.6% | 4,100 | +2.5% | 0.01% | +9.1% |
Q1 2018 | $233,000 | -7.2% | 4,000 | +2.6% | 0.01% | 0.0% |
Q4 2017 | $251,000 | +8.2% | 3,900 | +11.4% | 0.01% | -8.3% |
Q3 2016 | $232,000 | +4.0% | 3,500 | -2.8% | 0.01% | +9.1% |
Q2 2015 | $223,000 | -0.9% | 3,600 | 0.0% | 0.01% | 0.0% |
Q1 2015 | $225,000 | – | 3,600 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FIRST WILSHIRE SECURITIES MANAGEMENT INC | 367,754 | $10,911,000 | 4.08% |
AIGH Capital Management LLC | 244,500 | $7,254,000 | 1.91% |
Parkman Healthcare Partners LLC | 108,559 | $3,221,000 | 1.19% |
Worth Venture Partners, LLC | 60,831 | $1,927,000 | 1.13% |
Global Alpha Capital Management Ltd. | 323,731 | $9,605,000 | 1.04% |
Mesirow Financial Investment Management, Inc. | 6,892 | $204,000 | 0.99% |
MARATHON CAPITAL MANAGEMENT | 74,460 | $2,209,000 | 0.71% |
EMERALD ADVISERS, LLC | 455,880 | $13,526,000 | 0.70% |
EMERALD MUTUAL FUND ADVISERS TRUST | 356,865 | $10,588,000 | 0.61% |
Jackson Creek Investment Advisors LLC | 32,698 | $1,120,000 | 0.45% |